Assignee
SYNTHENA AG
CH·6 granted patents·4 pending applications·7 citations·filing 2014–2025
Top patents by PatentIndex Score
10 records- 0184US11104903B2Nucleic acids and methods for the treatment of Pompe diseaseSYNTHENA AG·Filed 2018·Granted Aug 31, 2021·3 cites·18 claims
- 0282US10059947B2Nucleic acids and methods for the treatment of Pompe diseaseSYNTHENA AG·Filed 2014·Granted Aug 28, 2018·4 cites·22 claims
- 0381US2024392300A1Nucleic Acids and Methods for the Treatment of Pompe DiseaseSYNTHENA AG·Filed 2024·Application pending·0 cites
- 0472US12091665B2Nucleic acids and methods for the treatment of Pompe diseaseSYNTHENA AG·Filed 2021·Granted Sep 17, 2024·0 cites·13 claims
- 0569US2024238321A1Modified oligomeric compounds comprising tricyclo-dna nucleosides and uses thereofSYNTHENA AG·Filed 2023·Application pending·0 cites
- 0662US2025270179A1Tricyclo-dna nucleoside precursors and processes for preparing the sameSYNTHENA AG·Filed 2025·Application pending·0 cites
- 0760US2021340534A1Mixed Tricyclo-DNA, 2'-Modified RNA Oligonucleotide Compositions and Uses ThereofSYNTHENA AG·Filed 2021·Application pending·0 cites
- 0858US11118179B2Mixed tricyclo-DNA, 2′-modified RNA oligonucleotide compositions and uses thereofSYNTHENA AG·Filed 2017·Granted Sep 14, 2021·0 cites·22 claims
- 0952US11872239B2Modified oligomeric compounds comprising tricyclo-DNA nucleosides and uses thereofSYNTHENA AG·Filed 2018·Granted Jan 16, 2024·0 cites·12 claims
- 1048US12319667B2Tricyclo-DNA nucleoside precursors and processes for preparing the sameSYNTHENA AG·Filed 2019·Granted Jun 3, 2025·0 cites·14 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →